Current therapeutic landscape and future treatment perspectives of MASH
(feeds.nature.com)
1.
2.
3.
Tertiary lymphoid structures harbour stem-like tumour-specific T cells
(feeds.nature.com)
4.
5.
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk
(feeds.nature.com)
6.
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
(feeds.nature.com)
Today's top topics:
apple
openai
anthropic
iphone 18 pro
iphone duo
google
ios 27
ai safety
apple watch series 12
iphone